|
26 Companies |
|
51 Products |
|
51 Products |
|
56 Mechanisms of Action |
|
3 Trials |
|
839 News |
|
| «12345678910111213...1617» |
- || rosuvastatin/telmisartan / Generic mfg.
Trial primary completion date: A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome (clinicaltrials.gov) - May 31, 2017
P4, N=204, Recruiting, Sponsor: Yuhan Corporation
Trial primary completion date: Oct 2017 --> May 2018
- | Trial completion: Diet, Obesity and Genes (DiOGenes) (clinicaltrials.gov) - May 31, 2017
P4, N=1020, Completed, Sponsor: University of Copenhagen
Trial primary completion date: Oct 2017 --> May 2018 Active, not recruiting --> Completed
- | Trial completion, Phase classification: Aldosterone, Microvascular Function and Salt-sensitivity (clinicaltrials.gov) - May 19, 2017
P=N/A, N=40, Completed, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed Recruiting --> Completed | Phase classification: P4 --> PN/A
- | Enrollment open: The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia (clinicaltrials.gov) - May 16, 2017
P=N/A, N=12, Recruiting, Sponsor: University of Texas at Austin
Recruiting --> Completed | Phase classification: P4 --> PN/A Not yet recruiting --> Recruiting
- | Trial completion, Enrollment change, Trial primary completion date: Healthy Bodies, Healthy Kids (clinicaltrials.gov) - May 12, 2017
P=N/A, N=50, Completed, Sponsor: Washington University School of Medicine
Not yet recruiting --> Recruiting Recruiting --> Completed | N=126 --> 50 | Trial primary completion date: Dec 2016 --> Mar 2017
- | New trial, Metastases: The Effects of Restricted Dietary of AGEs on the Glycemic Control, Oxidative Stress and Inflammation (clinicaltrials.gov) - May 10, 2017
P=N/A, N=44, Not yet recruiting, Sponsor: Dr Azita Hekmatdoost
- Trial completion, Enrollment change: Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents (clinicaltrials.gov) - May 5, 2017
P2/3, N=10, Completed, Sponsor: University of Manitoba
Recruiting --> Completed | N=126 --> 50 | Trial primary completion date: Dec 2016 --> Mar 2017 Recruiting --> Completed | N=60 --> 10
- | New trial: The DIET Trial - Dietetic Intervention in Psoriatic Arthritis (clinicaltrials.gov) - May 5, 2017
P=N/A, N=194, Completed, Sponsor: Federal University of S
- | Trial completion, Trial initiation date, Trial primary completion date: Frequency of Metabolic Syndrome in Down Syndrome Patients (clinicaltrials.gov) - May 4, 2017
P=N/A, N=96, Completed, Sponsor: Universidad de Guanajuato
Recruiting --> Completed | N=60 --> 10 Not yet recruiting --> Completed | Initiation date: May 2009 --> Sep 2009 | Trial primary completion date: May 2009 --> Dec 2009
- | Enrollment closed, Trial primary completion date: Exploring the Role of Adipocyte Fatty Acid Binding Protein in the Association of Obstructive Sleep Apnea and Metabolic Dysfunction (clinicaltrials.gov) - May 3, 2017
P=N/A, N=95, Active, not recruiting, Sponsor: The University of Hong Kong
Not yet recruiting --> Completed | Initiation date: May 2009 --> Sep 2009 | Trial primary completion date: May 2009 --> Dec 2009 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Sep 2017
- | New trial: Parenting Intervention and Metabolic Syndrome (clinicaltrials.gov) - May 3, 2017
P=N/A, N=391, Completed, Sponsor: Northwestern University
- | Trial completion: A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome (clinicaltrials.gov) - May 2, 2017
P=N/A, N=20, Completed, Sponsor: Tehran University of Medical Sciences
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Sep 2017 Recruiting --> Completed
- | Trial completion, Phase classification, Surgery, Bariatric surgery: ADIII: Effect of Bariatric Surgery "Digestive Adaptations III" on Cardiovascular Risk (clinicaltrials.gov) - May 2, 2017
P=N/A, N=30, Completed, Sponsor: University of Sao Paulo
Recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P2 --> PN/A
- | Enrollment open: The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal (clinicaltrials.gov) - Apr 29, 2017
P=N/A, N=10, Recruiting, Sponsor: University of Texas at Austin
Active, not recruiting --> Completed | Phase classification: P2 --> PN/A Not yet recruiting --> Recruiting
- | Trial completion, Trial primary completion date: Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth (clinicaltrials.gov) - Apr 27, 2017
P=N/A, N=255, Completed, Sponsor: Yale University
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Sep 2018 --> Mar 2017
- | Trial completion: Glycemic Index - Variability Among Individuals (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=124, Completed, Sponsor: Tufts University
Recruiting --> Completed | Trial primary completion date: Sep 2018 --> Mar 2017 Recruiting --> Completed
- | Trial completion: Bioactive Plant Foods: Effects on Functional Bioavailability and Genomic Stability (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=36, Completed, Sponsor: Tufts University
Recruiting --> Completed Active, not recruiting --> Completed
- | New trial: CCK1R Function in Patient Leukocytes (clinicaltrials.gov) - Apr 20, 2017
P=N/A, N=112, Completed, Sponsor: Mayo Clinic
- | goserelin acetate / Generic mfg., anastrozole / Generic mfg.
Phase classification, Trial termination, Trial primary completion date: Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome (clinicaltrials.gov) - Apr 18, 2017
P1, N=66, Terminated, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Phase classification: P=N/A --> P1 | Recruiting --> Terminated | Trial primary completion date: Sep 2010 --> Feb 2010; PI relocated
- | New trial: Periodized Aerobic Interval Training in Metabolic Syndrome (clinicaltrials.gov) - Apr 17, 2017
P=N/A, N=52, Completed, Sponsor: Universidade Estadual Paulista J
- | Trial completion, Phase classification, Enrollment change, Trial primary completion date: Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission (clinicaltrials.gov) - Apr 17, 2017
P=N/A, N=224, Completed, Sponsor: Vanderbilt University Medical Center
Phase classification: P=N/A --> P1 | Recruiting --> Terminated | Trial primary completion date: Sep 2010 --> Feb 2010; PI relocated Recruiting --> Completed | Phase classification: P1 --> PN/A | N=45 --> 224 | Trial primary completion date: Jan 2015 --> Apr 2016
- | Enrollment change, Trial termination, Trial primary completion date: Impact of Metabolic Syndrome on Flu Vaccine Efficacy (clinicaltrials.gov) - Apr 14, 2017
P=N/A, N=5, Terminated, Sponsor: Rockefeller University
Recruiting --> Completed | Phase classification: P1 --> PN/A | N=45 --> 224 | Trial primary completion date: Jan 2015 --> Apr 2016 N=10 --> 5 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Mar 2017; Target accrual not met
- | Trial completion: PAR Regulation of Platelet Function in Diabetic Patients (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=195, Completed, Sponsor: Vanderbilt University
N=10 --> 5 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Mar 2017; Target accrual not met Recruiting --> Completed
- | fezagepras (PBI-4050) / Liminal BioSci
Trial completion: Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome (clinicaltrials.gov) - Apr 11, 2017
P2, N=24, Completed, Sponsor: ProMetic BioSciences Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment change, Trial termination, Trial primary completion date: Health Improvement After Pregnancy (HIP) Program Randomized Control Trial (clinicaltrials.gov) - Apr 7, 2017
P=N/A, N=43, Terminated, Sponsor: Queen's University
Active, not recruiting --> Completed N=96 --> 43 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Apr 2016; Poor retention and recruitment,changes need to be made to the program
- | Phase classification: Effective Endurance Training in Metabolic Syndrome (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=30, Completed, Sponsor: Norwegian University of Science and Technology
N=96 --> 43 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Apr 2016; Poor retention and recruitment,changes need to be made to the program Phase classification: P2 --> P=N/A
- | omega-3 ethylester concentrate / Generic mfg.
Trial completion, Phase classification, Trial primary completion date: HEARTS: Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=338, Completed, Sponsor: Beth Israel Deaconess Medical Center
Phase classification: P2 --> P=N/A Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: May 2016 --> Jan 2015
- | New trial: The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=10, Not yet recruiting, Sponsor: University of Texas at Austin
- | New trial: The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia (clinicaltrials.gov) - Mar 24, 2017
P=N/A, N=12, Not yet recruiting, Sponsor: University of Texas at Austin
- | Kineret (anakinra) / SOBI
Enrollment change, Trial primary completion date: TestIL: Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome (clinicaltrials.gov) - Mar 21, 2017
P3, N=70, Recruiting, Sponsor: Mirjam Christ-Crain
Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: May 2016 --> Jan 2015 N=50 --> 70 | Trial primary completion date: Feb 2017 --> Jun 2017
- || metformin / Generic mfg., fenofibrate / Generic mfg.
Trial primary completion date: The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study (clinicaltrials.gov) - Mar 20, 2017
P2, N=124, Completed, Sponsor: University of Pennsylvania
N=50 --> 70 | Trial primary completion date: Feb 2017 --> Jun 2017 Trial primary completion date: Mar 2008 --> Dec 2007
- | Enrollment change, Trial termination, Trial primary completion date: Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=25, Terminated, Sponsor: The Cleveland Clinic
Trial primary completion date: Mar 2008 --> Dec 2007 N=45 --> 25 | Recruiting --> Terminated | Trial primary completion date: Apr 2015 --> Jan 2015
- | Enrollment closed, Enrollment change: Diet and Exercise Interventions to Increase Muscle Strength and Function (clinicaltrials.gov) - Mar 7, 2017
P=N/A, N=94, Active, not recruiting, Sponsor: South Dakota State University
N=45 --> 25 | Recruiting --> Terminated | Trial primary completion date: Apr 2015 --> Jan 2015 Not yet recruiting --> Active, not recruiting | N=200 --> 94
- | Trial completion, Enrollment change, Trial primary completion date: Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method (clinicaltrials.gov) - Mar 1, 2017
P=N/A, N=110, Completed, Sponsor: Joslin Diabetes Center
Not yet recruiting --> Active, not recruiting | N=200 --> 94 Enrolling by invitation --> Completed | N=500 --> 110 | Trial primary completion date: Jun 2017 --> Jan 2017
- | Trial completion, Phase classification, Enrollment change, Trial primary completion date: STRONG: Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=10, Completed, Sponsor: Georgetown University
Enrolling by invitation --> Completed | N=500 --> 110 | Trial primary completion date: Jun 2017 --> Jan 2017 Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=84 --> 10 | Trial primary completion date: Jul 2017 --> Feb 2017
- | Trial primary completion date: Stress and Sugar Synergy (clinicaltrials.gov) - Feb 17, 2017
P=N/A, N=26, Recruiting, Sponsor: University of California, Davis
Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=84 --> 10 | Trial primary completion date: Jul 2017 --> Feb 2017 Trial primary completion date: Apr 2015 --> Jun 2017
- | New trial: COMITII: Canola Oil Multi-center Intervention Trial II (clinicaltrials.gov) - Feb 16, 2017
P=N/A, N=28, Completed, Sponsor: Penn State University
- galantamine extended release / Generic mfg.
Trial completion: GALANTA-MS: Galantamine Effects in Patients With Metabolic Syndrome (clinicaltrials.gov) - Feb 15, 2017
P4, N=60, Completed, Sponsor: University of Sao Paulo
Trial primary completion date: Apr 2015 --> Jun 2017 Active, not recruiting --> Completed
- Trial primary completion date: A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults (clinicaltrials.gov) - Feb 15, 2017
P=N/A, N=20, Active, not recruiting, Sponsor: University of Missouri-Columbia
Active, not recruiting --> Completed Trial primary completion date: Nov 2016 --> Mar 2017
- | Enrollment open, Trial primary completion date: Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome (clinicaltrials.gov) - Feb 15, 2017
P1/2, N=12, Recruiting, Sponsor: University of Missouri-Columbia
Trial primary completion date: Nov 2016 --> Mar 2017 Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2017 --> Nov 2017
- Enrollment change: FMRIMetSynd: Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial (clinicaltrials.gov) - Feb 14, 2017
P=N/A, N=0, Withdrawn, Sponsor: Family Medicine Residency of Idaho
Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2017 --> Nov 2017 N=500 --> 0
- Trial completion, Enrollment change: AIMMY: Assessing Inherited Markers of Metabolic Syndrome in the Young (clinicaltrials.gov) - Feb 11, 2017
P=N/A, N=700, Completed, Sponsor: Eric Hoffman
N=500 --> 0 Active, not recruiting --> Completed | N=1500 --> 700
- New trial: Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies (clinicaltrials.gov) - Feb 9, 2017
P=N/A, N=30, Completed, Sponsor: Bristlecone Behavioral Health, Inc.
- Trial primary completion date: China Action on Spine and Hip Status (clinicaltrials.gov) - Feb 3, 2017
P=N/A, N=5000, Recruiting, Sponsor: Beijing Jishuitan Hospital
Active, not recruiting --> Completed | N=1500 --> 700 Trial primary completion date: Jun 2016 --> Jun 2017
- Enrollment closed, Trial primary completion date: The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study) (clinicaltrials.gov) - Feb 1, 2017
P=N/A, N=144, Active, not recruiting, Sponsor: University of East Anglia
Trial primary completion date: Jun 2016 --> Jun 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Mar 2017
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial primary completion date: METALIP: Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances (clinicaltrials.gov) - Jan 30, 2017
P=N/A, N=250, Recruiting, Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Mar 2017 Trial primary completion date: Jun 2016 --> Mar 2017
- New trial: Exercise Capacity and Dyspnea in Obese Patients With Metabolic Syndrome: Effects of Weight Loss (clinicaltrials.gov) - Jan 30, 2017
P=N/A, N=68, Completed, Sponsor: University of Ottawa
- Biomarker, New trial, HEOR: Exercise Training and Metabolic Syndrome (clinicaltrials.gov) - Jan 30, 2017
P=N/A, N=53, Completed, Sponsor: Universidade Estadual Paulista J
- Trial primary completion date: Effects of TA-65, a Telomerase Activator on Metabolic Syndrome (clinicaltrials.gov) - Jan 6, 2017
P=N/A, N=40, Recruiting, Sponsor: University of Connecticut
Trial primary completion date: Jun 2016 --> Mar 2017 Trial primary completion date: Dec 2016 --> Jun 2017
- Enrollment open, Trial primary completion date: Impact of Metabolic Syndrome on Flu Vaccine Efficacy (clinicaltrials.gov) - Jan 6, 2017
P=N/A, N=10, Recruiting, Sponsor: Rockefeller University
Trial primary completion date: Dec 2016 --> Jun 2017 Active, not recruiting --> Recruiting | Trial primary completion date: Dec 2016 --> Dec 2017